Archive | xLM's ContinuousTV Weekly Newsletter

AI Agentic Continuous Validation

#0100: AI & GxP Regulatory Current Moments (Part 1) - 10 Guiding Principles from FDA/EMA

Nagesh Nama, +1

•

Mar 20, 2026

LinkedIn Live

#099: Governing AI in Regulated Pharma R&D: Lessons from Merck’s Research Quality Leadership

Nagesh Nama, +1

•

Mar 11, 2026

AI Regulations

#098: Regulatory Alert: UK Makes AI/ML Usage Transparent in Clinical Trials

Nagesh Nama, +1

•

Mar 5, 2026

#097: FDA’s QMSR Is Here: What It Means for Med Device

Nagesh Nama, +1

•

Feb 25, 2026

ContinuousOS

#096: ContinuousOS in Sync with Google's Agentic AI Vision

Nagesh Nama, +1

•

Feb 19, 2026

Army of Agents

#095: The Frontier QA Organization: Governing a Swarm of Agents in GxP Pharma

Nagesh Nama, +1

•

Feb 12, 2026

#094: GxP in the Age of AI: From AstraZeneca's Head of Digital Strategy (LinkedIn Live event)

Nagesh Nama, +1

•

Feb 4, 2026

Continuous Intelligent Validation

#093: Continuous Intelligent Validation (cIV): From Months of Manual Validation to Minutes of Intelligent Execution

Nagesh Nama, +1

•

Jan 28, 2026

#092: Unscripted LinkedIn Live: GxP AI Implementations @ AstraZeneca

Nagesh Nama, +1

•

Jan 21, 2026

cIGA - Continuous Intelligent GxP Auditor

#091: Reengineering Vendor Audits for the AI Era

Nagesh Nama, +1

•

Jan 15, 2026

xLM Process Intelligence Audit

#090: How to Eliminate the Manual Bottlenecks That Break Enterprise GxP AI

Nagesh Nama, +1

•

Jan 8, 2026

xLM Process Intelligence Audit

#089: State of Enterprise AI 2025 by OpenAI

Nagesh Nama, +1

•

Dec 17, 2025